Zinc in microscopic calcifications isolated from thyroid fine needle aspiration may serve as a biomarker of thyroid nodule malignancy: A promising proof-of-concept
Source abstract
Abstract
Thyroid nodules (TNs) are common neck ultrasonography (US) findings, yet only 5-10% of these nodules harbor thyroid cancer (TC). When US characteristics are consistent with an intermediate or high suspicion for TN malignancy, fine needle aspiration for cytology (FNAC) is indicated. The main limitation of FNAC is that cytological results can be indeterminate in up to 30% of cases, necessitating reevaluation through repeated FNAC, expensive molecular testing, or diagnostic thyroid lobe resection. As such, there is a need for further refinement of current diagnostic algorithms for TNs without subjecting patients to additional invasive procedures. As calcifications detected during thyroid US are considered a high-risk feature for malignancy, we used the material remaining following routine thyroid FNAC to isolate microscopic calcifications (MCs). We then characterized the elemental composition, morphology, and crystal phases of these MCs, ultimately revealing differences between the MCs from benign and malignant TNs. Specifically, thyroid MCs were identified as calcium phosphate crystals containing varying levels of magnesium, sodium, iron, and zinc. MCs obtained from malignant TNs, mainly papillary thyroid carcinoma, were composed of sub-micrometer spherical particles, whereas MCs from benign TNs consisted of faceted particles. While samples from most patients with a final diagnosis of malignant TNs (50% of them with indeterminate cytology) harbored zinc-containing MCs, zinc was largely absent in MCs from benign TNs (23% with indeterminate or non-diagnostic cytology). Together, these data suggest that the presence of zinc in MCs isolated from samples collected during routine FNAC may potentially offer value as a biomarker of TN malignancy. STATEMENT OF SIGNIFICANCE: As up to 40% of patients assessed for thyroid malignancy do not receive a definite diagnosis following thyroid nodule (TN) fine needle aspiration (FNA), there is a pressing need to improve the accuracy of current diagnostic algorithms. Chemical analyses of microscopic calcifications (MCs) may serve as a diagnostic target. We developed a straightforward protocol to chemically characterize MCs from excess material collected from TNs during routine FNA and found that these MCs differed between benign and malignant TNs. Specifically, zinc in TN-derived MCs may indicate a higher nodule malignancy risk, thus increasing the diagnostic accuracy of the FNA procedure, reducing the need for recurrent biopsies and diagnostic surgical procedures, and decreasing the costs, uncertainty, and stress faced by affected patients.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Medical Imaging and Pathology Studies · Thyroid Cancer Diagnosis and Treatment · Parathyroid Disorders and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Biomineralization process in hard tissues: the interaction complexity within protein and inorganic counterparts10.1016/j.actbio.2020.04.049 ↗
2. Structure and mechanical quality of the collagen-mineral nano-composite in bone10.1039/B402005G ↗
3. Focused ion beam-SEM 3D analysis of mineralized osteonal bone: lamellae and cement sheath structures10.1016/j.actbio.2020.11.002 ↗
4. Biomineralization: from material tactics to biological strategy
5. Improvement of organisms by biomimetic mineralization: a material incorporation strategy for biological modification10.1016/j.actbio.2020.06.038 ↗
6. Controlled remineralization of enamel in the presence of amelogenin and fluoride10.1016/j.biomaterials.2008.10.019 ↗
7. Pathological calcification of biomaterials10.1016/B978-0-12-816137-1.00065-9 ↗
8. Biomaterials Strategies for development of decellularized heart valve scaffolds for tissue engineering10.1016/j.biomaterials.2022.121675 ↗
9. A materials science vision of extracellular matrix mineralization
10. Contemporary thyroid nodule evaluation and management10.1210/clinem/dgaa322 ↗
11. The diagnosis and management of thyroid nodules a review10.1001/jama.2018.0898 ↗
12. ACR thyroid Imaging, reporting and data system (TI-RADS): White paper of the ACR TI-RADS committee10.1016/j.jacr.2017.01.046 ↗
13. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer10.1089/thy.2015.0020 ↗
14. Comparison of five thyroid ultrasound stratification systems for differentiation of benign and malignant nodules and to avoid biopsy using histology as reference standard10.1016/j.eprac.2021.04.411 ↗
15. The 2017 bethesda system for reporting thyroid cytopathology10.1089/thy.2017.0500 ↗
16. Combining the American thyroid association's ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules10.1089/thy.2019.0575 ↗
17. Diagnostic performances of the afirma gene sequencing classifier in comparison with the gene expression classifier: a meta-analysis10.1002/cncy.22332 ↗
18. ThyroSeq v3 for bethesda III and IV: an institutional experience10.1002/cncy.22362 ↗
19. Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: Validation of a novel custom DNA-based NGS panel
20. Molecular aspects of thyroid calcification10.3390/ijms21207718 ↗
21. The association between tumor tissue calcification, obesity, and thyroid cancer invasiveness in a cohort study10.4158/EP-2020-0057 ↗
22. Molecular aspects and prognostic significance of microcalcifications in human pathology: a narrative review10.3390/ijms22010120 ↗
23. Multiple pathways for pathological calcification in the human body
24. Relationships between pathology and crystal structure in breast calcifications: An in situ X-ray diffraction study in histological sections10.1038/npjbcancer.2016.29 ↗
25. Calcification in breast lesions: pathologists’ perspective10.1136/jcp.2006.046201 ↗
26. Carbonate and cation substitutions in hydroxylapatite in breast cancer micro-calcifications10.1180/mgm.2021.23 ↗
27. Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas10.1016/j.jsb.2017.12.002 ↗
28. New relationships between breast microcalcifications and cancer10.1038/sj.bjc.6605873 ↗
29. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using raman spectroscopy
30. Microcalcifications in breast cancer: An active phenomenon mediated by epithelial cells with mesenchymal characteristics10.1186/1471-2407-14-286 ↗
31. On the chemical composition of psammoma bodies microcalcifications in thyroid cancer tissues10.1016/j.jpba.2020.113534 ↗
32. Localization and characterization of thyroid microcalcifications: a histopathological study10.1371/journal.pone.0224138 ↗
33. Chemical diversity of calcifications in thyroid and hypothetical link to disease10.1016/j.crci.2015.02.008 ↗
34. Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor?
35. Structure and morphology of nanocrystalline calcifications in thyroid10.21272/jnep.8(1).01031 ↗
36. Characterization through scanning electron microscopy and Fourier transform infrared spectroscopy of microcalcifications present in fine needle aspiration smears10.5802/crchim.187 ↗
37. Validation of american thyroid association ultrasound risk-adapted approach for repeating cytology in benign thyroid nodules10.1089/thy.2020.0351 ↗
38. Psammoma bodies and thyroid carcinoma
39. Psammoma body and its precursors in papillary thyroid carcinoma: a study by fine-needle aspiration cytology
40. Molecular testing for indeterminate thyroid nodules: performance of the afirma gene expression classifier and ThyroSeq panel10.1002/cncy.21993 ↗
41. M.T. Santos, M. Rodrigues, S. Shizukuda, F. Andrei, Articles clinical decision support analysis of a microRNA-based thyroid molecular classifier : a real-world, prospective and multicentre validation study, 82 (2022) 1–9. doi:10.1016/j.ebiom.2022.104137.10.1016/j.ebiom.2022.104137 ↗
42. Raman spectroscopy reveals that biochemical composition of breast microcalcifications correlates with histopathologic features10.1158/0008-5472.CAN-19-3204 ↗
43. Scott · 2022 · 9
44. A study on inorganic elements in psammomas from ovarian & thyroid cancer
45. The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma10.1007/s00268-013-2107-5 ↗
46. A Mineralization Adsorption and Mobility Study of Hydroxyapatite Surfaces in the Presence of Zinc and Magnesium Ions10.1021/la00024a054 ↗
47. Zinc incorporation into hydroxylapatite10.1016/j.biomaterials.2009.01.043 ↗
48. Characterization and structural analysis of zinc-substituted hydroxyapatites10.1016/j.actbio.2009.04.014 ↗
49. Selective protein adsorption property and characterization of nano-crystalline zinc-containing hydroxyapatite10.1016/j.actbio.2005.09.002 ↗
50. The Important role of the apoptotic effects of Zinc in the development of cancers10.1002/jcb.22049 ↗
51. Zinc and its role in immunity and inflammation10.1016/j.autrev.2014.11.008 ↗
52. Zinc in infection and inflammation
53. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients10.1007/s12011-016-0768-2 ↗
54. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells10.1111/j.1349-7006.2007.00446.x ↗
55. Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer10.1186/s12943-015-0486-y ↗
56. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer10.1016/j.mito.2005.02.001 ↗
57. Effects of zinc on human skeletal alkaline phosphatase activity in vitro10.1007/s002239900597 ↗
58. Biomineralogical signatures of breast microcalcifications10.1126/sciadv.ade3152 ↗